GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity.


Journal

Nature cancer
ISSN: 2662-1347
Titre abrégé: Nat Cancer
Pays: England
ID NLM: 101761119

Informations de publication

Date de publication:
05 2023
Historique:
received: 14 12 2022
accepted: 06 04 2023
medline: 29 5 2023
pubmed: 12 5 2023
entrez: 11 5 2023
Statut: ppublish

Résumé

The transfer of intact mitochondria between heterogeneous cell types has been confirmed in various settings, including cancer. However, the functional implications of mitochondria transfer on tumor biology are poorly understood. Here we show that mitochondria transfer is a prevalent phenomenon in glioblastoma (GBM), the most frequent and malignant primary brain tumor. We identified horizontal mitochondria transfer from astrocytes as a mechanism that enhances tumorigenesis in GBM. This transfer is dependent on network-forming intercellular connections between GBM cells and astrocytes, which are facilitated by growth-associated protein 43 (GAP43), a protein involved in neuron axon regeneration and astrocyte reactivity. The acquisition of astrocyte mitochondria drives an increase in mitochondrial respiration and upregulation of metabolic pathways linked to proliferation and tumorigenicity. Functionally, uptake of astrocyte mitochondria promotes cell cycle progression to proliferative G2/M phases and enhances self-renewal and tumorigenicity of GBM. Collectively, our findings reveal a host-tumor interaction that drives proliferation and self-renewal of cancer cells, providing opportunities for therapeutic development.

Identifiants

pubmed: 37169842
doi: 10.1038/s43018-023-00556-5
pii: 10.1038/s43018-023-00556-5
pmc: PMC10212766
doi:

Substances chimiques

GAP-43 Protein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

648-664

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR002548
Pays : United States
Organisme : NCI NIH HHS
ID : F31 CA264849
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR002549
Pays : United States
Organisme : NCI NIH HHS
ID : F32 CA260735
Pays : United States
Organisme : NINDS NIH HHS
ID : R35 NS127083
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007024
Pays : United States
Organisme : NCI NIH HHS
ID : F30 CA250254
Pays : United States
Organisme : NCI NIH HHS
ID : K00 CA253768
Pays : United States
Organisme : NCI NIH HHS
ID : K99 CA248611
Pays : United States
Organisme : NIH HHS
ID : S10 OD019972
Pays : United States
Organisme : NCI NIH HHS
ID : K08 CA234416
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023. The Author(s).

Références

Nat Rev Mol Cell Biol. 2020 Apr;21(4):204-224
pubmed: 32071438
Sci Rep. 2015 Mar 13;5:9073
pubmed: 25766410
Nat Rev Cancer. 2016 Oct;16(10):635-49
pubmed: 27634447
Front Pharmacol. 2021 Sep 13;12:723798
pubmed: 34588983
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Transl Oncol. 2022 Jan;15(1):101251
pubmed: 34700192
Cell Death Differ. 2015 Jul;22(7):1181-91
pubmed: 25571977
Cancers (Basel). 2020 Apr 01;12(4):
pubmed: 32244839
J Neurosci. 2002 Jan 1;22(1):239-47
pubmed: 11756507
Nat Commun. 2015 Oct 07;6:8472
pubmed: 26442449
J Immunol Methods. 2009 Aug 15;347(1-2):70-8
pubmed: 19567251
Semin Cancer Biol. 2022 Jul;82:162-175
pubmed: 33640445
Methods Mol Biol. 2019;1895:11-26
pubmed: 30539526
Nat Commun. 2020 Jul 30;11(1):3811
pubmed: 32732914
Nat Commun. 2018 Jul 12;9(1):2691
pubmed: 30002366
Nat Cell Biol. 2018 Jul;20(7):745-754
pubmed: 29950572
Int J Mol Sci. 2019 Nov 29;20(23):
pubmed: 31795330
PLoS One. 2011;6(12):e29537
pubmed: 22216308
Cancer Cell. 2011 Apr 12;19(4):498-511
pubmed: 21481791
Science. 2004 Feb 13;303(5660):1007-10
pubmed: 14963329
Stem Cell Reports. 2017 Aug 8;9(2):438-450
pubmed: 28689994
Nat Protoc. 2006;1(1):241-5
pubmed: 17406239
Biochem Biophys Res Commun. 2020 Jan 29;522(1):205-212
pubmed: 31759629
EBioMedicine. 2019 Apr;42:238-251
pubmed: 30917935
EMBO J. 2018 Dec 3;37(23):
pubmed: 30322894
Biochem J. 2021 Jan 15;478(1):21-39
pubmed: 33245115
Front Cell Dev Biol. 2016 Oct 13;4:109
pubmed: 27790613
Cancers (Basel). 2021 May 02;13(9):
pubmed: 34063271
Biochem Soc Trans. 2019 Apr 30;47(2):625-638
pubmed: 30902924
Glia. 2008 Dec;56(16):1799-808
pubmed: 18661554
Mol Cell Neurosci. 2009 May;41(1):62-73
pubmed: 19249369
Cell. 2022 Aug 4;185(16):2899-2917.e31
pubmed: 35914528
Nat Rev Neurol. 2018 Aug;14(8):482-495
pubmed: 29985475
J Cell Sci. 2019 Oct 10;132(19):
pubmed: 31515278
Front Immunol. 2015 May 15;6:227
pubmed: 26029212
PLoS One. 2009 Jul 20;4(7):e6314
pubmed: 19617915
Brain. 2011 May;134(Pt 5):1331-43
pubmed: 21515906
Nucleic Acids Res. 2021 Jul 2;49(W1):W388-W396
pubmed: 34019663
Nature. 2015 Dec 3;528(7580):93-8
pubmed: 26536111
J Neurosci. 1997 May 15;17(10):3515-24
pubmed: 9133376
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Crit Rev Oncog. 2014;19(5):327-36
pubmed: 25404148
PLoS One. 2011;6(7):e21800
pubmed: 21789182
Neuro Oncol. 2022 Apr 1;24(4):541-553
pubmed: 34543427
Circ Res. 2002 Mar 8;90(4):390-7
pubmed: 11884367
Cell. 2018 Sep 20;175(1):101-116.e25
pubmed: 30220459
Neuro Oncol. 2017 Mar 1;19(3):383-393
pubmed: 27591677
Commun Biol. 2020 Jun 12;3(1):305
pubmed: 32533056
Nucleic Acids Res. 2016 Jan 4;44(D1):D1251-7
pubmed: 26450961
J Transl Med. 2013 Apr 10;11:94
pubmed: 23574623
Nature. 2016 Jul 27;535(7613):551-5
pubmed: 27466127
J Biol Chem. 2013 Mar 29;288(13):9153-64
pubmed: 23408428
Sci Rep. 2021 Jul 15;11(1):14556
pubmed: 34267246
Nat Rev Mol Cell Biol. 2020 Feb;21(2):85-100
pubmed: 31636403
Biochem Biophys Res Commun. 2020 Nov 26;533(1):139-147
pubmed: 32943183
Nat Neurosci. 2017 May;20(5):661-673
pubmed: 28346452
J Neuropathol Exp Neurol. 2021 Jun 4;80(6):541-551
pubmed: 33990845
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Front Cell Dev Biol. 2016 Sep 28;4:107
pubmed: 27734015
Cancer Res. 2019 May 1;79(9):2285-2297
pubmed: 30622116
Sci Transl Med. 2019 Aug 7;11(504):
pubmed: 31391321
Genesis. 2018 Feb;56(2):
pubmed: 29243279
J Cell Sci. 2012 Mar 1;125(Pt 5):1089-98
pubmed: 22399801
Neuro Oncol. 2017 Oct 01;19(10):1316-1326
pubmed: 28419303
J Neurosci. 2017 Jul 19;37(29):6837-6850
pubmed: 28607172
Neuro Oncol. 2016 Apr;18(4):479-85
pubmed: 26995789
Elife. 2017 Feb 15;6:
pubmed: 28195532
J Cancer Stem Cell Res. 2014;2:
pubmed: 27547779

Auteurs

Dionysios C Watson (DC)

Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Case Comprehensive Cancer Center, Cleveland, OH, USA.
University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, USA.

Defne Bayik (D)

Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Case Comprehensive Cancer Center, Cleveland, OH, USA.
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, USA.

Simon Storevik (S)

Department of Biomedicine, University of Bergen, Bergen, Norway.
Department of Neurology, Haukeland University Hospital, Bergen, Norway.

Shannon Sherwin Moreino (SS)

Department of Biomedicine, University of Bergen, Bergen, Norway.

Samuel A Sprowls (SA)

Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Jianhua Han (J)

Department of Biomedicine, University of Bergen, Bergen, Norway.

Mina Thue Augustsson (MT)

Department of Biomedicine, University of Bergen, Bergen, Norway.

Adam Lauko (A)

Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Medical Scientist Training Program, Case Western Reserve University, Cleveland, OH, USA.

Palavalasa Sravya (P)

Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.

Gro Vatne Røsland (GV)

Department of Biomedicine, University of Bergen, Bergen, Norway.

Katie Troike (K)

Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Karl Johan Tronstad (KJ)

Department of Biomedicine, University of Bergen, Bergen, Norway.

Sabrina Wang (S)

Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Katharina Sarnow (K)

Department of Biomedicine, University of Bergen, Bergen, Norway.

Kristen Kay (K)

Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Taral R Lunavat (TR)

Department of Biomedicine, University of Bergen, Bergen, Norway.
Department of Neurology, Molecular Neurogenetics Unit-West, Massachusetts General Hospital, Boston, MA, USA.

Daniel J Silver (DJ)

Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Sahil Dayal (S)

Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Justin Vareecal Joseph (JV)

Stipe Therapeutics, Aarhus, Denmark.

Erin Mulkearns-Hubert (E)

Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, USA.

Lars Andreas Rømo Ystaas (LAR)

Department of Biomedicine, University of Bergen, Bergen, Norway.

Gauravi Deshpande (G)

Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Joris Guyon (J)

University of Bordeaux, INSERM, BRIC, Pessac, France.

Yadi Zhou (Y)

Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Capucine R Magaut (CR)

University of Bordeaux, INSERM, BRIC, Pessac, France.

Juliana Seder (J)

Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Laura Neises (L)

Cancer Metabolism Group, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg, Luxembourg.

Sarah E Williford (SE)

University of Alabama at Birmingham, Birmingham, AL, USA.

Johannes Meiser (J)

Cancer Metabolism Group, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg, Luxembourg.

Andrew J Scott (AJ)

Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.

Peter Sajjakulnukit (P)

Cancer Biology Graduate Program, University of Michigan, Ann Arbor, MI, USA.

Jason A Mears (JA)

Case Comprehensive Cancer Center, Cleveland, OH, USA.
School of Medicine, Case Western Reserve University, Cleveland, OH, USA.

Rolf Bjerkvig (R)

Department of Biomedicine, University of Bergen, Bergen, Norway.
NorLux Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg, Luxembourg.

Abhishek Chakraborty (A)

Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Case Comprehensive Cancer Center, Cleveland, OH, USA.

Thomas Daubon (T)

University of Bordeaux, CNRS, IBGC, Bordeaux, France.

Feixiong Cheng (F)

Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Case Comprehensive Cancer Center, Cleveland, OH, USA.

Costas A Lyssiotis (CA)

Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.
Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.
Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA.

Daniel R Wahl (DR)

Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.

Anita B Hjelmeland (AB)

University of Alabama at Birmingham, Birmingham, AL, USA.

Jubayer A Hossain (JA)

Department of Biomedicine, University of Bergen, Bergen, Norway.

Hrvoje Miletic (H)

Department of Biomedicine, University of Bergen, Bergen, Norway. hrvoje.miletic@uib.no.
Department of Pathology, Haukeland University Hospital, Bergen, Norway. hrvoje.miletic@uib.no.

Justin D Lathia (JD)

Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. lathiaj@ccf.org.
Case Comprehensive Cancer Center, Cleveland, OH, USA. lathiaj@ccf.org.
Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, USA. lathiaj@ccf.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH